Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: High-throughput computational screening pipeline to identify dual inhibitors of EGFR kinase and BRD4(1).

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques: High Throughput Screening Assay

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: Evaluation and characterization of the BRD4 docking data fusion model.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques:

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: Docking scores versus reported BRD4 pActivities (pIC 50 /pK d /pK i ) and Pearson correlation results of representative BRD4 inhibitors by chemotypes.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques:

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: Circles represent purchased compounds tested in the BRD4(1) assay, categorized by their activity against BRD4 and EGFR. Only compounds that were confirmed active against BRD4 were further tested for activity against EGFR; any of the black circles therefore could also be EGFR actives.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques: Activity Assay

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: ( A ) Average concentration-response profile of compound 2870 and known BRD4 inhibitor I-BET151 using the BRD4(1) biochemical alpha screen assay (n = 3). Emission data was normalized using DMSO and is reported as % response. Average IC 50 of 2870 was found to be 9.02 μ M against BRD4(1). ( B ) The EGFR kinase radioisotope filter binding assay was performed at a substrate concentration of 10 μ M against 2870 and Staurosporine (n = 3). Average IC 50 of 2870 was found to be 0.044 μ M against EGFR kinase.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques: Concentration Assay, Filter-binding Assay

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: Activity from the alphascreen assay against BRD4(1) and closest topological similarity to known BRD4(1) binders is also shown. Five other compounds comprising the same sulfonamide scaffold as 8302 were also confirmed actives but are not displayed.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques: Activity Assay, Amplified Luminescent Proximity Homogenous Assay

Journal: Scientific Reports

Article Title: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

doi: 10.1038/srep16924

Figure Lengend Snippet: Binding affinity of 2870.

Article Snippet: Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.

Techniques: Binding Assay

Journal: The Journal of Biological Chemistry

Article Title: Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal

doi: 10.1074/jbc.RA118.005798

Figure Lengend Snippet: Effect of combining BL-V8-310 with other LRAs on the reactivation of latent HIV. A, ACH-2 cells, and B, U1 cells were treated with BL-V8-310 (5–50 n m ) alone or in combination with prostratin (100 n m ), JQ1 (100 n m ), GSK525762A (100 n m ), SAHA (500 n m ), or panobinostat (100 n m ) for 48 h, and supernatant p24 was measured. C, J-Lat 10.6 cells, and D, J-Lat 6.3 cells were treated with BL-V8-310 (100–400 n m ) alone or in combination with prostratin (200 n m ), JQ1 (500 n m ), GSK525762A (500 n m ), SAHA (1 μ m ), or panobinostat (10 n m ) for 24 h, and the number of GFP-positive cells was measured. A–D, right panels, bliss independence model was utilized to define the synergism/antagonism of drug combinations. Synergism was defined as Δ fa xy > 0, and Δ fa xy < 0 indicated antagonism. Data are shown as means ± S.D. of three independent experiments.

Article Snippet: Prostratin (PKC activator), SAHA/vorinostat, panobinostat (HDAC inhibitor), JQ1, and GSK525762A (BRD4 inhibitor) were purchased from Sigma, Santa Cruz Biotechnology (Dallas, TX), MedChem Express (Monmouth Junction, NJ), BioVision (Milpitas, CA), and ChemScene (Monmouth Junction, NJ), respectively.

Techniques:

Journal: Marine Drugs

Article Title: Inhibitors of BRD4 Protein from a Marine-Derived Fungus Alternaria sp. NH-F6

doi: 10.3390/md15030076

Figure Lengend Snippet: Inhibition rates of compounds 1 – 24 against BRD4 protein a .

Article Snippet: BRD4 (BD1) inhibitor screening assay kit was purchased from Cisbio Bioassays (Codolet, France).

Techniques: Inhibition